Delivering and optimising an extensive prescription medicines portfolio.
We work with Biotech and Pharma companies of all sizes, providing the knowledge and experience needed to successfully navigate the Irish market.

Comprehensive first market entry support from regulatory through distribution. As your Pharmaceutical Licensing Partner, we provide strategic guidance on accelerating product launches and patient access.

Growing Companies
Flexible partnerships that scale with your ambitions. Choose our full-service Irish Pharmaceutical Commercialisation or modular components tailored to your evolving needs and patient populations.

Specialist therapeutic area expertise for portfolio expansion. Senior-level strategic thinking combined with agile execution for complex or speciality products that enhance patient well-being.
Our team brings over 150 years of collective pharmaceutical experience from the world’s leading healthcare organisations, including AbbVie, AstraZeneca, Johnson & Johnson, MSD, Novartis, and Pfizer. We've successfully launched more than 50 medicines across biotech, specialty care, primary care and niche medical indications.
Unlike large pharmaceutical organisations, we move quickly and act decisively to deliver to your timeline. Our services are tailored and individualised to your specific requirements and need for scale.

We have one of Ireland’s leading Pharmaceutical Sales teams in secondary and primary care. Supported by strong medical networks and established relationships, we are well-positioned to deliver effective, sustainable market entry and growth.

Pre-launch planning, field force deployment, medical and marketing strategy, customer excellence programmes with tailored digital KPIs.

Key opinion leader partnerships, medical education programmes, and scientific communication that resonates with healthcare professionals.

HPRA submissions, Target Product Profiles (TPPs), Advisory Boards, Clinical Trials, and Lifecycle Management with Full Compliance Oversight.

National patient initiatives, disease awareness and prevention campaigns, and advocacy programmes that support better health outcomes.

Pricing strategies, payer engagement, and reimbursement pathways that maximise patient access whilst optimising commercial returns.

Approved WDA and licensed GDP distribution facilities, providing national daily supply to all hospitals and community pharmacies. Early access programmes and clinical trials supply are supported.
Whether you're planning your first medicine launch or expanding an existing portfolio, we bring the expertise and operational excellence to make your market entry successful.
Schedule a consultation to discuss your pharmaceutical market access goals and explore how Athena can support your success in Ireland.